Feature stories
NITD: Combating neglected tropical diseases
The Novartis Institute for Tropical Diseases (NITD) aims to discover novel treatments and prevention methods for major tropical diseases.
World diabetes day
Novartis unites with the International Diabetes Federation (IDF) to raise awareness for diabetes. In recognition of World Diabetes Day on November 14, Novartis will light the global headquarters in blue.
Joining forces against the new wave of tuberculosis
Once thought a disease of the past, tuberculosis is again becoming an international health threat. HIV-related resistance, rapidly increasing travel and migration, drug shortages and failure of patients and doctors to adhere to treatment schedules, are contributing to the spread of this deadly infectious disease.
Zambezi Expedition puts malaria in the spotlight
Novartis is part of a multi-agency partnership supporting an ambitious journey along the Zambezi River, highlighting the difficulty of delivering mosquito nets and malaria treatment to remote African communities.
NVGH blazes a trail: Effective and affordable vaccines for the developing world
Many eminent scientists are contributing to the Novartis Vaccines Institute for Global Health, the first research center established by a major vaccine manufacturer with a nonprofit mission - to discover and develop vaccines for “neglected” diseases of the developing world.
February 29 is Rare Disease Day in Europe
Rare diseases affect nearly 36 million people in the European Union alone. Learn more about this pioneer initiative in Europe to raise awareness of rare diseases and the Novartis commitment to address unmet needs.
International Leprosy Congress in Hyderabad
Novartis and the Novartis Foundation for Sustainable Development are working toward the elimination of leprosy. “Toward a world without leprosy” was the motto of the 17th International Leprosy Congress in Hyderabad, India. A world free of leprosy is within reach.
Renin: A new approach
When Soren Anderson opened his morning newspaper recently, he noticed a headline about an award-winning new medicine. As he read the article, Soren grew intrigued by the thought that this new medicine that fights high blood pressure in a unique way might help in his long fight against the disease.
NITD: Rejuvenating Research in Neglected Diseases
The Novartis Institute for Tropical Diseases (NITD), part of Novartis Corporate Research, set out five years ago to apply leading-edge tools of biomedical research to tropical diseases such as dengue fever and tuberculosis that take a daunting toll among patients in the developing world. Any therapies discovered at NITD will be made available to poor patients without profit.
Novartis and leading research organizations join forces to fight Dengue fever
As part of the Singapore Dengue Consortium, the Novartis Institute for Tropical Diseases (NITD) and 10 other scientific bodies will share information and findings to better understand the virus which causes fever, severe joint pain and in some cases hemorrhage, shock and death.
Coartem in Africa: Gaining Momentum on the Ground
The main battleground is Africa, where malaria kills more than a million people every year, mainly pregnant women and children younger than five years of age. “Malaria is more than an ordinary disease on this continent,” says the Honorable Richard Nduhura, Uganda’s Minister of State for Health.
About Novartis
We provide medicines to treat and prevent diseases, ease suffering and improve quality of life.
Our products
We have a broad healthcare portfolio.